[1]
2025. PO55 | Evaluation of safety and efficacy of emicizumab prophylaxis in pediatric patients with hemophilia A – a single centre experience: M.L. Tramontano, M. Coppola, S. Coppola, M. Schiavulli | UOSD Centro Regionale Pediatrico Malattie della Coagulazione, Santobono Pausilipon Children Hospital, AORN, Napoli, Italy. Bleeding, Thrombosis and Vascular Biology. 4, s1 (Aug. 2025). DOI:https://doi.org/10.4081/btvb.2025.324.